Connor, Clark & Lunn Investment Management Ltd. Sangamo Therapeutics, Inc Transaction History

Connor, Clark & Lunn Investment Management Ltd.

$20 Billion
Q4 2024

10 transactions

Quarter	Operation	Price Per share	shares change	shares Held
Q4 2022 Feb 10, 2023	SELL	$2.77 - $5.07 $706,471 - $1.29 Million	-255,044 Reduced 42.16%	349,894 $1.1 Million
Q3 2022 Nov 10, 2022	BUY	$4.27 - $6.39 $934,327 - $1.4 Million	218,812 Added 56.67%	604,938 $2.96 Million
Q2 2022 Aug 05, 2022	BUY	$3.28 - $6.21 $891,215 - $1.69 Million	271,712 Added 237.48%	386,126 $1.6 Million
Q1 2022 May 12, 2022	SELL	$5.23 - $7.82 $129,416 - $193,505	-24,745 Reduced 17.78%	114,414 $665,000
Q4 2021 Feb 10, 2022	SELL	$7.29 - $10.97 $1.1 Million - $1.66 Million	-150,869 Reduced 52.02%	139,159 $1.04 Million
Q3 2021 Nov 12, 2021	BUY	$9.01 - $12.01 $947,095 - $1.26 Million	105,116 Added 56.85%	290,028 $2.61 Million
Q2 2021 Aug 12, 2021	BUY	$10.17 - $12.64 $961,126 - $1.19 Million	94,506 Added 104.54%	184,912 $2.21 Million
Q1 2021 May 13, 2021	SELL	$10.88 - $17.05 $509,804 - $798,911	-46,857 Reduced 34.14%	90,406 $1.13 Million
Q4 2020 Feb 16, 2021	BUY	$9.23 - $18.18 $1.1 Million - $2.17 Million	119,470 Added 671.44%	137,263 $2.14 Million
Q3 2020 Nov 12, 2020	BUY	$9.38 - $12.48 $166,898 - $222,056	17,793 New	17,793 $168,000

Others Institutions Holding SGMO

# of Institutions

118

Shares Held

43.8M

Call Options Held

576K

Put Options Held

1.17M

Vanguard Group Inc Valley Forge, PA

9.37M
Shares

$11 Million
0.0% of portfolio
Wasatch Advisors Inc Salt Lake City, UT

9.23M
Shares

$10.8 Million
0.05% of portfolio
State Street Corp Boston, MA

5.02M
Shares

$5.87 Million
0.0% of portfolio
Black Rock Inc. New York, NY

4.7M
Shares

$5.5 Million
0.0% of portfolio
Jim Simons Renaissance Technologies LLC | New York, Ny

3.08M
Shares

$3.61 Million
0.0% of portfolio

View Full List

About SANGAMO THERAPEUTICS, INC

Ticker SGMO
Exchange NASDAQ
Sector Healthcare
Industry Biotechnology
Shares Outstandng 156,552,992
Market Cap $183M
Description
Sangamo Therapeutics, Inc., a clinical-stage biotechnology company, focuses on translating science into genomic medicines that transform patients' lives using platform technologies in gene therapy, cell therapy, genome editing, and genome regulation. The company offers zinc finger protein (ZFP), a technology platform for making zinc finger nucle...

More about SGMO

Track This Portfolio

Portfolio Update

Get notified when there are updates to the investment portfolio of Connor, Clark & Lunn Investment Management Ltd., based on Form 13F filings with the SEC.

News

Stay updated on Connor, Clark & Lunn Investment Management Ltd. with notifications on news.

Account